GW Pharmaceuticals Inc. (fka GWPRF)

[greengold24k]

I too a look at both companies annual reports last night and I'm even further convinced that GW is the clear winner.

GW spent $70 mil last year on R&D. INSY spent $30 mil. The little bit of information I found shocking was that INSY only spent $5mil of CBD research!!!

GW has nearly 3 times the number of patents and patents pending compared to INSY. GW is first to the phase 3 trails giving it a great advantage.

Lawsuits. GW is not current involved or had any involvement in previous years.. INSY on the other hand has had involvement in serval lawsuits, most recently about a year ago.

Is it just me or does something seem fishy about INSY being a serious competitor? Could INSY even be considered a marijuana investment with there lack of exposure?

To me GW is the clear winner and will get even attention when we get FDA later this year